Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer

Pancreatic cancer is one of the most aggressive, heterogeneous and fatal type of human cancers for which more effective therapeutic agents are urgently needed. Here, we investigated the sensitivity of a panel of seven human pancreatic cancer cell lines (HPCCLs) to treatment with various tyrosine kin...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Tanzeel, Seddon, Alan M., Dalgleish, Angus G., Khelwatty, Said, Ioannou, Nikolaos, Mudan, Satvinder, Modjtahedi, Helmout
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640362/
https://www.ncbi.nlm.nih.gov/pubmed/33125153
http://dx.doi.org/10.3892/or.2020.7822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640362/
https://www.ncbi.nlm.nih.gov/pubmed/33125153
http://dx.doi.org/10.3892/or.2020.7822

Ejemplares similares